what's the difference between tirzepatide and zepbound (Zepbound) – A New Treatment for Obstructive Sleep Apnea Obesity — BetterNight The Zepbound Dossier : A

At least, there's some good basketball on

Amylin expected to be the next big target Amylin analogs are a different modality (non-incretin) as it works by increasing satiety and increasing leptin sensitivity, which is a distinct mechanism compared to GLP-1

For the same reason, Wilcoxon ranked test was used to study the differences between pre- and post-surgical values

Further studies with larger sample sizes and adequate evaluation of NAION are warranted to clarify this potential risk, the researchers wrote

A reasonable monitoring cadence for most patients is: Every 3 months for the first year Every 6 months once values are stable Ask specifically: "What A1C reduction are we targeting, and at what point would we reassess or adjust the approach?" For context on realistic A1C changes over time, see: How Much Can A1C Drop in 3 Months

Joint pain decreases for many people